| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef4f341fe4f2caf061611a818576e40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00 |
| filingDate |
2014-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33ad90d22a9f190c494defbfe5fe6c81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2cb22990fb97b372ca8dcaae714a697 |
| publicationDate |
2015-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NI-201400138-A |
| titleOfInvention |
NEW DOSAGE AND FORMULATION. |
| abstract |
A pharmaceutical composition for inhalation comprising aclidinium as a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, which provides a released dose of aclidinium equivalent to about 322 micrograms of aclidinium as the free base. |
| priorityDate |
2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |